Ibrahim AlZaim
Overview
Explore the profile of Ibrahim AlZaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
170
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alotaiq N, Khalifa A, Youssef A, El-Nagar E, Elwali N, Habib H, et al.
FASEB J
. 2024 Dec;
38(24):e70273.
PMID: 39726401
Individuals with metabolic syndrome have a high risk of developing cardiovascular disorders that is closely tied to visceral adipose tissue dysfunction, as well as an altered interaction between adipose tissue...
2.
AlZaim I, El-Nikhely N, Al-Saidi A, Mougharbil N, Darwiche N, Abou-Kheir W, et al.
Life Sci
. 2023 Dec;
334:122225.
PMID: 38084675
Aims: Prostate cancer is among the highest incidence malignancies in men with a prevalence rate increasing in parallel to the rising global trends in metabolic disorders. Whereas a sizeable body...
3.
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity
AlZaim I, de Rooij L, Sheikh B, Borgeson E, Kalucka J
Nat Rev Endocrinol
. 2023 Sep;
19(12):691-707.
PMID: 37749386
Adipose tissue is an endocrine organ and a crucial regulator of energy storage and systemic metabolic homeostasis. Additionally, adipose tissue is a pivotal regulator of cardiovascular health and disease, mediated...
4.
Festa J, AlZaim I, Kalucka J
Curr Opin Genet Dev
. 2023 Jun;
81:102055.
PMID: 37279621
Cardiovascular disease is the leading cause of death globally. Endothelial cells (ECs), the key units of all vascular segments, have a significant impact on the health and disease of organisms....
5.
Hammoud S, AlZaim I, Mougharbil N, Koubar S, Eid A, Eid A, et al.
Biochem Pharmacol
. 2023 Feb;
210:115420.
PMID: 36848861
No abstract available.
6.
7.
Bakkar N, AlZaim I, El-Yazbi A
Clin Sci (Lond)
. 2022 Nov;
136(22):1631-1651.
PMID: 36383188
Sodium-glucose transporter-2 inhibitors (SGLT-2i) and glucagon-like peptide 1 (GLP-1) receptor agonists are newer antidiabetic drug classes, which were recently shown to decrease cardiovascular (CV) morbidity and mortality in diabetic patients....
8.
AlZaim I, Eid A, Abd-Elrahman K, El-Yazbi A
Biochem Pharmacol
. 2022 Nov;
206:115337.
PMID: 36347272
Cardiometabolic diseases present an escalating global health and economic burden. Such a surge is driven by epidemic prevalence rates of metabolic disorders, such as obesity and type 2 diabetes, and...
9.
Shaaban H, AlZaim I, El-Mallah A, Aly R, El-Yazbi A, Wahid A
Life Sci
. 2022 Sep;
308:120956.
PMID: 36103959
Non-alcoholic fatty liver disease (NAFLD) is an important health threat that is strongly linked to components of metabolic syndrome, particularly the low-grade inflammatory changes. Significantly, several of the available anti-diabetic...
10.
Al-Koussa H, AlZaim I, El-Sabban M
J Clin Med
. 2022 Aug;
11(16).
PMID: 36013171
The notion of blood coagulation dates back to the ancient Greek civilization. However, the emergence of innovative scientific discoveries that started in the seventeenth century formulated the fundamentals of blood...